Anika Therapeutics | ANIK - Action





Action Changement Date
Abbott USD 6.49B 220M 2025-12
Agios Pharmaceuticals USD 32.92M 886K 2025-12
Anika Therapeutics USD 18.79M 2.5M 2025-12
Arrowhead Research USD -173.08M 173.08M 2024-12
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 132.07M 11.1M 2025-12
Integra LifeSciences USD 492.73M 3.63M 2025-12
Intrexon USD 287K 68K 2022-12
J&J USD 14.19B 45M 2025-12
Karyopharm Therapeutics USD 3.97M 1.03M 2025-09
Ligand Pharmaceuticals USD 9.13M 2.77M 2025-12
MacroGenics USD 7.91M 840K 2025-12
Merit Medical Systems USD 333.7M 7.15M 2025-12
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Sanofi EUR 22.69B 1.81B 2025-12
Stryker USD 5.31B 60M 2025-12
Surmodics USD 15.17M 230K 2024-09
Veracyte USD 20.55M 219K 2025-12
Zimmer Biomet Holdings USD 2.29B 197.3M 2025-12